Herbicide resistance crisis targeted by new Oxford tech firm MoA Technology
20 October 2019
MoA Technology, borne out of Oxford University research, launches to confront the global herbicide resistance crisis. The Company launches with £6.3m Series A funding round.
Theolytics Limited comes out of stealth mode with Dr Ken Powell announced as Chair of the Board
25 June 2019
Virology spinout Theolytics emerges from stealth with £2.5m seed and Dr Ken Powell as chair.
The BioEscalator officially launches
18 June 2019
Baroness Nicola Blackwood of North Oxford, Parliamentary Under Secretary of State for Innovation, has officially opened the Oxford BioEscalator.
PepGen receives a £1.6M grant from Innovate UK
2 November 2018
PepGen has been awarded a grant of £1.6 M from Innovate UK, the UK’s innovation agency. The company’s project, entitled ‘Application of a novel peptide delivery platform to nucleic acid therapeutics in degenerative and rare diseases’, will run for 20 months, and this funding will be instrumental in supporting the pre-clinical development of PepGen’s innovative technology.
First tenant moves into the BioEscalator
10 September 2018
PepGen is a biotech company that focuses on peptide-mediated delivery of nucleic acids.